InvestorsHub Logo
Followers 861
Posts 28265
Boards Moderated 1
Alias Born 03/16/2014

Re: None

Sunday, 09/23/2018 6:10:19 PM

Sunday, September 23, 2018 6:10:19 PM

Post# of 30141
MATRIX DECISION PROBABILITY ANALYSIS FOR DEA RESCHEDULING CBD/EPIDIOLEX


CBD

Schedule I (12%)

Schedule II (33%)

Schedule III (45%)


Schedule IV (7%)

Schedule V (3%)


EPIDIOLEX

Schedule II (5%)

Schedule III (8%)

Schedule IV (65%)

Schedule V (22%)


FINAL MATRIX DECISION ANALYSIS PREDICTION

CBD — Schedule III

Epidiolex — Schedule IV



Sleek

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.